People Management for Principal Investigators, November 2nd and 3rd

Every principal investigator wants to build and maintain a lab that attracts and retains outstanding trainees and staff members. Juggling this endeavor with everything else the PI must do — writing papers, teaching, mentoring, gaining and maintaining funding, creating collaborative and productive relationships with other PIs — can be challenging at best. This 1.5-day course, led by Melanie Erskine and Rachel Dresbeck from the Office of the Senior Vice President for Research, will help you learn to manage people with a focus on the particular needs of running a lab or research group.

When: Thursday, Nov. 2, 9 a.m. to 5 p.m. and Friday, Nov. 3, 9 a.m. to 12 p.m.
Location:  School of Nursing 107 (Day 1) and School of Nursing 116 (Day 2)
Register on Compass

In this course you will learn:

  • Strategies for approaching the role of “coach” in the lab —developing your leadership style
  • Recruitment and retention strategies — building (and maintaining) the best team for your lab
  • Steps to take when coaching doesn’t work — performance management in the lab
  • Resources that are available to you to support you and your lab staff

Enrollment is limited; there is no cost to participants.

OHSU seeks chief scientific officer to direct, unify and further catalyze discovery

OHSU logoOHSU is commencing a search for a biomedical researcher and academic leader to serve as the university’s chief scientific officer and vice dean for research in the OHSU School of Medicine. The CSO/VDR will have responsibility for the leadership and management of the research enterprise of OHSU.

The CSO will report to the president of OHSU and, for research matters in the School of Medicine, will serve in the role of vice dean for research, reporting to the dean. This dual reporting structure is intended to facilitate integration and coordination of OHSU’s overarching research agenda.

“OHSU is seeking an internationally renowned biomedical researcher and academic leader who will prioritize strategic initiatives for research and bring together the goals of the basic, translational, clinical, and public health research programs at OHSU,” said OHSU President Joe Robertson, M.D. “This individual will provide the leadership and oversee an articulated team of school-level leaders, resulting in the ability to synthesize our research vision across the university and take our research enterprise to the next level.”

Faculty leaders across the institution gave input into the role of the chief scientific officer through such groups as the OHSU Research Strategic Advisory Council, Faculty Senate and the Collaborative Research Leadership Group and Faculty Council in the School of Medicine.

President Robertson and School of Medicine Dean Sharon Anderson, M.D., will charge the committee with its task. Anderson will oversee committee operations, and has appointed David Ellison, M.D., associate vice president for clinical and translational research, and professor of medicine, OHSU School of Medicine, as chair. The committee will provide a report to the president and the dean. Anyone with an interest is encouraged to provide input to members of the search committee, which includes research leaders from across the institution. (View search committee.)

“If all goes well, we hope to have a chief scientific officer in place in time for the start of next school year,” Robertson said. “I’m excited for the vision, guidance and support that this new leader will bring to our outstanding research enterprise at OHSU.”

Prenatal care for undocumented immigrant mothers leads to improved healthcare for their children

Prenatal care infographicA study led by Jonas Swartz, M.D., in the OHSU School of Medicine found that expanding preventive care in pregnancy for unauthorized immigrant women reduced infant deaths, increased participation in screenings, vaccines. Swartz and senior author Maria Rodriguez, M.D., M.P.H., published the findings in Obstetrics & Gynecology.

Unauthorized immigrant women with access to care received 7.2 more prenatal visits, or nearly the nine to 12 visits recommended for a typical pregnancy. They also were 74 percent more likely to get a fetal ultrasound, 61 percent more likely to get diabetes screening and 19 percent more likely to receive the Tdap vaccine, which protects newborns against tetanus, diphtheria and pertussis, or whooping cough.

The analysis found that making prenatal care available reduced the likelihood that these women had an extremely low birth weight infant by 1.33 per 1,000 births. It also reduced infant mortality by 1.01 per 1,000 births – a reduction that by comparison was larger than the 30-year decline in infant mortality from Sudden Infant Death Syndrome, or SIDS, that was attributed to the “Back to Sleep” campaign.

Read OHSU News for more about Swartz and Rodriguez’s research.

OCTRI information session: Updates from the CTSA

OHSU logoIf you are interested in training programs, regulatory expertise, and other resources needed to conduct translational research, we encourage you to attend this session to learn more about the services and programs offered by the Oregon Clinical & Translational Research Institute at OHSU. OCTRI recently received a renewed Clinical and Translational Science Award and this session will provide information on continuing and new OCTRI services, and changes and opportunities you can expect to see.

OCTRI information and Q&A session
School of Nursing, room 107
Thursday, Oct. 19, noon to 1 p.m.

The OCTRI team will present information on the range of services available.

  • Funding awards, research education, clinical research space and regulatory knowledge
  • Grant proposal development
  • Clinical research development
  • Informatics, including Epic for research and REDCap
  • Recruitment, including resources and electronic data
  • A collaborative national network for all aspects of clinical trial planning and execution
  • Clinical and translational inpatient/outpatient research center with assets ranging from labs to study coordinators

OCTRI recently received a renewed Clinical and Translational Science Award from the National Center for Advancing Translational Sciences. The session will provide information on continuing and new OCTRI services, and changes and opportunities you can expect to see at OCTRI.

Presenters: David Ellison, director; Cindy Morris, co-director; Rob Schuff, informatics director; and Kitt Swartz, Trial Innovation Network liaison. Get all of your questions answered.

Renowned scientist to lead precision oncology for the OHSU Knight Cancer Institute

Gordon MillsInternationally renowned scientist Gordon B. Mills, M.D., Ph.D., is joining OHSU to lead precision oncology for the Knight Cancer Institute.

One of the most highly cited medical scientists in the world, Mills will bring a breadth of research and leadership experience to OHSU. He was recruited from the MD Anderson Cancer Center in Houston, where he has been a clinical and research leader since 1994.

At OHSU, Mills will integrate research across multiple areas, including early detection, immunotherapy and systems biology. He will also recruit and mentor young scientists and investigators — with a goal of changing the landscape of cancer science.

Mills has authored or co-authored nearly 900 published research papers and been referenced more than 70,000 times in peer-reviewed research studies, placing him among the top 1 percent of all authors in medicine.

See OHSU News for more about Mills and his appointment.

NRSA Workshop: Technical components – October 24

If you’re planning to apply for a pre- or post-doctoral NRSA fellowship from the NIH in the near future, we encourage you to attend this workshop to learn about essential, non-research elements of your fellowship application. Topics covered include how to set up your proposal in InfoEd, how to develop a budget, how to manage reference letters, biosketches and PMCID numbers, and elements of a great training plan.

This upcoming workshop is led by Johanna Colgrove, manager of the MD/PhD program, Gavin Hamilton, grants and contracts administrator with the Office of Proposal and Award Management, and Rachel Dresbeck, Ph.D., director of research development at OHSU.

NRSA Application Workshop
Tuesday, October 24
3 to 4.30 p.m.
Richard Jones Hall 4320

This workshop is open to applicants but may also be useful for department-based research administrators and faculty. All are welcome!

Questions? Write


Michael Chiang recognized for contributions to medical informatics

Chiang Michael _CaseyEye_0211

Michael Chiang, M.D., will be inducted into the American College of Medical Informatics on November 5 during the 2017 American Medical Informatics Association Annual Symposium. ACMI is an honorary College of elected informatics fellows from the United States and abroad selected for significant and sustained contributions to the field.

Chiang is Knowles Professor of Ophthalmology and Medical Informatics and Clinical Epidemiology at OHSU and is vice chair in the Department of Ophthalmology. He also leads the Oregon State Elks Center for Ophthalmic Informatics. As a clinician-scientist, he conducts research in the application of biomedical informatics to clinical ophthalmology. Chiang’s clinical practice focuses on pediatric ophthalmology and adult strabismus. His research examines telemedicine for diagnosis of retinopathy of prematurity and other ophthalmic diseases, implementation and evaluation of electronic health record systems, modeling of clinical workflow and computer-based image analysis for clinical diagnosis.

Chiang directs an NIH-funded T32 training program in translational visual science for graduate students and postdoctoral fellows, teaches in both the ophthalmology and biomedical informatics departments and has directly mentored over 40 graduate students, medical students, and postdoctoral fellows. His research has been continuously funded by the National Institutes of Health since 2003 and his group has published over 100 peer-reviewed journal papers.

Chiang will be inducted by Christopher G. Chute, M.D., Dr.PH., F.A.C.M.I., Bloomberg Distinguished Professor at Johns Hopkins University.

K12 Emergency Care Research Scholar Training opportunity

Emergency roomThe Department of Emergency Medicine is seeking applicants interested in training for a research career focused on Emergency Care Research topics. The training opportunity is for physicians and clinician-scientists.

Qualified scholars will be physicians who have completed residency or fellowships in emergency medicine other specialties, such as trauma surgery, pediatrics, hematology or internal medicine. Qualified clinician-scientists will have a Ph.D. or equivalent research training, such as nurses, psychologists, or pharmacists.

Co-Directors of the OHSU NIH K12 Emergency Care research program are Craig Newgard, M.D., M.P.H., a professor of emergency medicine in the School of Medicine, and Cynthia Morris, Ph.D., M.P.H., a professor of medical informatics and clinical epidemiology.

Visit for more information on applying.

Xiaolu “Lulu” Cambronne awarded an NIH New Innovator Award

Lulu CambronneThe National Institutes of Health today awarded a highly competitive research grant to Xiaolu (Lulu) Cambronne, Ph.D., a research assistant professor at the OHSU Vollum Institute. The grant, $1.5 million over five years, was given for Cambronne’s innovative approaches to addressing major challenges in biomedical research.

The grant is part of the NIH Director’s New Innovator Awards, established in 2007 to support early-career investigators who are conducting high-risk, high-impact research. Cambronne was one of 55 New Innovators awarded in 2017.

Cambronne will be looking at how changes in NAD availability might affect age-related pathologies. This is one of the biggest unknown mysteries in why age is a risk factor and, because NAD availability affects any disease in which age is a risk factor, her research has the potential to have very broad impacts in conditions ranging from neurodegenerative disorders to cardiovascular diseases and Type II diabetes.

Cambronne led a group to make a DNA-based fluorescent biosensor specific for free NAD, which allows the metabolite to be monitored. The research was reported in Science in June 2016. With these direct measurements of NAD, Cambronne and her group will address the current model and explore this hypothesis in both spatial and temporal resolution.

The research will not only generate knowledge about the metabolite but also determine, in a disease context, what the critical NAD concentration for health is and when and where this metabolite declines in a disease’s progress. More importantly, this will potentially provide information about intervention treatment and whether a particular treatment actually affects the metabolite availability.

OHSU receives NIH award to pioneer a national center for digital health innovation

OHSU has been awarded two grants totaling $62 million from the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to support the use of health data, algorithms and information systems to bridge basic science and clinical research.

The newly awarded grant provides OHSU with $25 million over five years to establish and lead the new National Center for Data to Health, or CD2H, in order to foster collaboration across more than 50 medical research institutions within the Clinical and Translational Science Awards network. OHSU’s CTSA, the Oregon Clinical and Translational Science Institute will be partnering with Dr. Haendel.

The CD2H will be led by Melissa Haendel, Ph.D., co-director of the NCATS-funded Biomedical Data Translator and the Monarch Initiative, and co-director of the OHSU Library; Kristi Holmes, Ph.D., Northwestern University; Sean Mooney, Ph.D., University of Washington; Christopher Chute, Dr.P.H., M.D., Johns Hopkins University; and John Wilbanks, Sage Bionetworks.

Read the full announcement on the OHSU News Hub.

The new CTSA Program National Center for Data to Health is supported by the National Center for Advancing Translational Sciences at the National Institutes of Health (grant U24TR002306).

The Biomedical Data Translator is funded by the National Center for Advancing Translational Sciences (grant OT3TR002019OT3TR002019).

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.